Thrombolysis for stroke.
Brott
T
T
Department of Neurology, University of Cincinnati, Ohio, USA.
D002543:Cerebral Hemorrhage / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000191:economics; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D005060:Europe; D006801:Humans; D009316:National Institutes of Health (U.S.); D010919:Placebos; D010960:Plasminogen Activators / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D010919:Placebos; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator